Development of antivirals for the treatment of COVID-19

CERSusChem and CIBFar (Center for Innovation in Biodiversity and Drug Discovery) are collaborating in a project sponsored by FAPESP towards the development of antivirals for the treatment of COVID-19. For further information: https://cibfar.ifsc.usp.br/covid-19/